US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco Nasdaq Biotechnology ETF

34.37

-0.0500-0.15%

Post-market: 34.370.00000.00%19:30 EDT

Volume:134.91K

Turnover:4.64M

Market Cap:105.52M

PE:- -

High:34.78

Open:34.78

Low:34.20

Close:34.42

52wk High:36.84

52wk Low:25.00

Shares:3.07M

Float Shares:3.07M

Volume Ratio:2.41

T/O Rate:4.39%

Dividend:0.39

Dividend Rate:1.14%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Sensorion doubles down on GJB2 gene therapy as SENS-601 enters Phase I/II

Vertex Pharmaceuticals Incorporated : Jefferies Raises Target Price to $640 from $633

THOMSON REUTERS

Hong Kong Stock Market Pulse | CRO Sector Shares Advance as Innovative Drug Contract Orders Grow in Both Volume and Price, Global AI4S Collaborations Poised to Deliver Gains

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Aytu BioPharma Q4 Revenue Beats Analyst Estimates on EXXUA Sales

Vertex's Kidney Drug Success Sparks a 22% Surge for This Rival Biotech

Update: US Equity Indexes, Crude Oil Prices Mixed in Midday Trading

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Eledon Pharmaceuticals (ELDN), Viking Therapeutics (VKTX) and Amgen (AMGN)

Amgen Inc Stock (AMGN) Moved Up by 3.90% on Sep 22: Facts Behind the Movement

Competitive profile of Amgen’s dazodalibep still ‘open question,’ says Citi

Truist sees ‘significant positive readthrough’ for Maze from Vertex data

Maze jumps 25% to $27.99 after Vertex kidney disease data

Amgen Rises After Autoimmune Drug Meets Late-Stage Trial Goal

Amgen Says Dazodalibep Meets Primary Endpoint in Phase 3 Sjögren's Disease Trial

Amgen Shares up 3% After Co's Autoimmune Disease Drug Succeeds in Late-Stage Trial

THOMSON REUTERS

Amgen Says Phase 3 Trial Shows Dazodalibep Cuts Systemic Disease Activity in Sjögren’s Disease

Vertex Pharmaceuticals Incorporated Says Inaxaplin Reduces UACR by -42.7% at Week 13 in AMKD with Modest Proteinuria

Amgen Announces Positive Topline Phase 3 Results for Dazodalibep in Moderate-to-Severe Systemic SjÖGren's Disease

THOMSON REUTERS

Amgen: Dazodalibep Showed Statistically Significant & Clinically Meaningful Improvement in Systemic Disease Activity

THOMSON REUTERS

Amgen: Phase 3 Oasiz 303 Study of Dazodalibep in Moderate-to-Severe Symptomatic SjÖGren’s Disease Expected to Complete in Q4 2026

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/IBBQ/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IBBQ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","market":"US","secType":"STK","nameCN":"Invesco Nasdaq Biotechnology ETF","latestPrice":34.37,"timestamp":1790971200000,"preClose":34.42,"halted":0,"volume":134914,"hourTrading":{"tag":"盘后","latestPrice":34.37,"preClose":34.37,"latestTime":"19:30 EDT","volume":23,"amount":793.71,"timestamp":1790983804820,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.0014526438117374858,"floatShares":3070000,"shares":3070000,"eps":0,"marketStatus":"Market Closed","change":-0.05,"latestTime":"10-02 16:00:00 EDT","open":34.78,"high":34.78,"low":34.2,"amount":4640242.504378,"amplitude":0.016851,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":34.42,"sharesOutstanding":2520001,"nav":34.4248,"aum":106440372.14,"dividendRate":0.01135,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":34.5,"preClose":34.42,"latestTime":"07:58 EDT","volume":100,"amount":3450,"timestamp":1790942314618,"change":0.08,"changeRate":0.002324,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":34.37,"preClose":34.37,"latestTime":"19:30 EDT","volume":23,"amount":793.71,"timestamp":1790983804820,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.412124809157592,"impliedVol":0.1226,"impliedVolPercentile":0.5299},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","floatShares":3070000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.412124809157592,"shares":3070000,"dividePrice":0.3901,"high":34.78,"amplitude":0.016851,"preClose":34.42,"low":34.2,"week52Low":25,"pbRate":"--","week52High":36.84,"institutionHeld":0,"latestPrice":34.37,"eps":0,"divideRate":0.01135,"volume":134914,"delay":0,"ttmEps":0,"open":34.78,"prevYearClose":28.3962,"prevWeekClose":35,"prevMonthClose":35.14,"prevQuarterClose":35.14,"fiveDayClose":35,"twentyDayClose":36.26,"sixtyDayClose":33.97},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBBQ\",params:#limit:5,,,undefined,":[{"date":"2026-09-21","symbol":"IBBQ","amount":0.23037,"announcedDate":"2026-09-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-21","defaultRemindTime":1789997400000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-25","payableDate":"2026-09-21","currency":"USD","dateTimestamp":1789963200000,"payDate":"2026-09-25"},{"date":"2026-06-22","symbol":"IBBQ","amount":0.03422,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"IBBQ","amount":0.03609,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"IBBQ","amount":0.0906,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"IBBQ","amount":0.09576,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBBQ\",market:\"US\",,,undefined,":[{"executeDate":"2021-09-20","recordDate":"2021-09-21","paymentDate":"2021-09-30","value":0.04324,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-31","value":0.10511,"currency":"USD"},{"executeDate":"2022-03-21","recordDate":"2022-03-22","paymentDate":"2022-03-31","value":0.03778,"currency":"USD"},{"executeDate":"2022-06-21","recordDate":"2022-06-22","paymentDate":"2022-06-30","value":0.04264,"currency":"USD"},{"executeDate":"2022-09-19","recordDate":"2022-09-20","paymentDate":"2022-09-23","value":0.03769,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBBQ\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBBQ\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669108132","title":"Sensorion doubles down on GJB2 gene therapy as SENS-601 enters Phase I/II","url":"https://stock-news.laohu8.com/highlight/detail?id=2669108132","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669108132?lang=en_us&edition=fundamental","pubTime":"2026-09-23 14:24","pubTimestamp":1790144664,"startTime":"0","endTime":"0","summary":"An update from Sensorion SAS ( ($FR:ALSEN) ) is now available. Sensorion has sharpened its strategic focus on SENS-601, a single-vector AAV gene th...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sensorion-doubles-down-on-gjb2-gene-therapy-as-sens-601-enters-phase-i-ii?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sensorion-doubles-down-on-gjb2-gene-therapy-as-sens-601-enters-phase-i-ii?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TBXU","CNCR","LFSC","IBBQ","BK4585","SENS","GNOM","FBT","BK4082","SYNB","IBB","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669999174","title":"Vertex Pharmaceuticals Incorporated : Jefferies Raises Target Price to $640 from $633","url":"https://stock-news.laohu8.com/highlight/detail?id=2669999174","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669999174?lang=en_us&edition=fundamental","pubTime":"2026-09-23 11:36","pubTimestamp":1790134588,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nFWN45E0RF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2468319806.SGD","LU0234570918.USD","BK4585","IDNA","IE00B19Z9P08.USD","IBB","BIB","IE00BZ9MQY76.HKD","PBE","LU1674673428.USD","LU1069344957.HKD","LU2462157665.USD","LU0320765992.SGD","SG9999001176.USD","VRTX","LU0061475181.USD","IE00B4R5TH58.HKD","LU2362540622.SGD","IE00B19Z3581.USD","GNMX","LU0889565916.HKD","LU0432979614.USD","LU1035775433.USD","LU2456880835.USD","IE00B19Z3B42.SGD","IE0002141913.USD","LU2417539215.USD","IE0009355771.USD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU1093756168.USD","IE0002270589.USD","LU0058720904.USD","SGXZ57979304.SGD","BK4588","LU1585245621.USD","TBXU","BBH","LU0109394709.USD","LU2362541273.HKD","IE00B19Z9Z06.USD","LU2237438978.USD","BK4139","SG9999013999.USD","IE00BFTCPJ56.SGD","BK4567","LU1093756325.SGD","IE00B894F039.SGD","LU1778281490.HKD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122623050","title":"Hong Kong Stock Market Pulse | CRO Sector Shares Advance as Innovative Drug Contract Orders Grow in Both Volume and Price, Global AI4S Collaborations Poised to Deliver Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=1122623050","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122623050?lang=en_us&edition=fundamental","pubTime":"2026-09-23 10:40","pubTimestamp":1790131228,"startTime":"0","endTime":"0","summary":"Shares of contract research organization (CRO) companies trading in Hong Kong moved mostly higher during Wednesday's session. As of the time of writing, Joinn Laboratories (China) Co Ltd (06127)...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK1161","VXUS","06978","KCAI","IBBQ","BK1574","BK4585","LNGR","159992","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669171122","title":"Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2669171122","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669171122?lang=en_us&edition=fundamental","pubTime":"2026-09-23 04:34","pubTimestamp":1790109240,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  rallied 1.40% to $152.67 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index  remaining mostly unchanged at 7,764.64 and the Dow Jones Industrial Average  falling 0.36% to 51,863.69.This was the stock's second consecutive day of gains.Gilead Sciences Inc. closed 2.94% below its 52-week high of $157.29, which the company achieved on February 11th.The stock outperformed some of its competitors Tuesday, as Johnson & Johnson  fell 0.10% to $269.19, Pfizer Inc.  rose 0.68% to $27.93, and Abbott Laboratories  rose 0.69% to $103.69.Trading volume  remained 1.3 million below its 50-day average volume of 6.2 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 22, 2026.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934455863.HKD","LU2089984988.USD","LU0859254822.USD","LU0114720955.EUR","LU1839511570.USD","SG9999015952.SGD","LU0882574055.USD","LU0122379950.USD","BK4139","LU1037948541.HKD","IE00B19Z3581.USD","LU0320765992.SGD","LU1674673428.USD","BIB","IE00B7SZLL34.SGD","LU0861579265.USD","LU1585245621.USD","LU2468319806.SGD","IBB","LU2324357040.USD","BK4588","LU0058720904.USD","LU0289739699.SGD","LU1023059063.AUD","LU1674673691.USD","LU1061106388.HKD","LU1571399168.USD","LU1066053197.SGD","GILD","BK4566","IE0002270589.USD","LU1057294990.SGD","LU2357627491.SGD","BBH","BK4550","BK4578","LU1430594728.SGD","LU0823416689.USD","LU2112291526.USD","BK4585","LU1934455194.USD","LU1037948897.HKD","BK4583","MEDI","LU1778281490.HKD","SG9999015945.SGD","SG9999015986.USD","LU0109394709.USD","LU0889565916.HKD","IE00BSNM7G36.USD","SG9999015978.USD","LU0965509010.AUD","TBXU","IE00B3T34201.USD","LU0965509101.SGD","LU1934455277.USD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU0965508806.USD","BK4568","LU1066051498.USD","IBBQ","TMED","LU2087621335.USD","BK4532","LU0234570918.USD","BMED","IE00B19Z3B42.SGD","LU0965509283.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669577122","title":"Aytu BioPharma Q4 Revenue Beats Analyst Estimates on EXXUA Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2669577122","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669577122?lang=en_us&edition=fundamental","pubTime":"2026-09-23 04:17","pubTimestamp":1790108275,"startTime":"0","endTime":"0","summary":"Aytu BioPharma Q4 revenue beats analyst estimates on EXXUA salesOverviewUS pharmaceutical firm's fiscal Q4 revenue rose 6.4%, beating analyst expectationsCompany reported near break-even net loss for ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nL1N45E0WU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999001440.SGD","BK4533","IE00B4R5TH58.HKD","IBB","LU1061106388.HKD","LU0109394709.USD","LU0868494617.USD","AYTU","BK4566","LU1571399168.USD","BK4599","LU0320765992.SGD","BK4581","TBXU","LU0889565916.HKD","IE00BJJMRZ35.SGD","LU2112291526.USD","IE0002141913.USD","PBE","BK4534","IE00BJT1NW94.SGD","BK4007","LU2468319806.SGD","BK4585","IE0009355771.USD","LU1983299246.USD","BK4139","LU1057294990.SGD","AMGN","PJP","LU0122379950.USD","BIB","IE00BFTCPJ56.SGD","LU0058720904.USD","LU1023059063.AUD","BBH","BK4588","IE00B2B36J28.USD","LU2242646821.SGD","LU0289739699.SGD","LU2089984988.USD","IBBQ","LU2242652126.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669412656","title":"Vertex's Kidney Drug Success Sparks a 22% Surge for This Rival Biotech","url":"https://stock-news.laohu8.com/highlight/detail?id=2669412656","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669412656?lang=en_us&edition=fundamental","pubTime":"2026-09-23 00:47","pubTimestamp":1790095620,"startTime":"0","endTime":"0","summary":"Shares of biopharmaceutical company Maze Therapeutics jumped after competitor Vertex Pharmaceuticals reported positive study results for its kidney disease drug, signaling strong commercial potential ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","IE0002141913.USD","SGXZ57979304.SGD","IE00B19Z9Z06.USD","IDNA","LU0889565916.HKD","TBXU","BK4588","LU2362541513.USD","LU1035775433.USD","LU2462157665.USD","LU0079474960.USD","LU0256863811.USD","LU1778281490.HKD","VRTX","LU1093756168.USD","LU1674673428.USD","BK4532","XBI","PBE","LU1430594728.SGD","BK4567","LU2324357040.USD","IE00B19Z3581.USD","IE00BFTCPJ56.SGD","LU2236285917.USD","LU1815336091.USD","IE00BJT1NW94.SGD","IE00BZ9MQY76.HKD","LU0234570918.USD","LU1585245621.USD","IBB","LU2089984988.USD","BIB","LU0058720904.USD","LU1069344957.HKD","GNMX","LU2456880835.USD","IBBQ","BK4023","VERX","LU2237438978.USD","IE0009355771.USD","LU0289739699.SGD","BK4585","IE00B2B36J28.USD","MAZE","LU1559883803.SGD","IE00B894F039.SGD","LU0432979614.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669268991","title":"Update: US Equity Indexes, Crude Oil Prices Mixed in Midday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2669268991","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669268991?lang=en_us&edition=fundamental","pubTime":"2026-09-23 00:35","pubTimestamp":1790094905,"startTime":"0","endTime":"0","summary":"(Updates with index/price moves and company/geopolitical news from the first paragraph.)US equity indexes traded mixed, with materials leading gainers and financials fronting decliners after midday on","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IJR","JEPQ","GSLC","ACWI","TECS","SFY","TOPT","MNQmain","IBBQ","AMGN",".IXIC","SDOW","VYM","DDM","IJH","SCHD","SQQQ","REZ","QQQE","SPDN","SPXL","SPY",".SPX","HIBS",".DJI","QQQJ","MYMmain","NDX","VTV","GPIQ","QLD","QQQA","TSPY","DJX","RSPN","GRNY","RSP","SSO","EQR","SPXU","QQQ","RSPU","TBXU","SPYV","DIA","BIB","NOBL","QQQY","DGRW","IVE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669757123","title":"Analysts Offer Insights on Healthcare Companies: Eledon Pharmaceuticals (ELDN), Viking Therapeutics (VKTX) and Amgen (AMGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669757123","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669757123?lang=en_us&edition=fundamental","pubTime":"2026-09-22 23:20","pubTimestamp":1790090418,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Eledon Pharmaceuticals (ELDN), Viking Therapeutics (...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-eledon-pharmaceuticals-eldn-viking-therapeutics-vktx-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-eledon-pharmaceuticals-eldn-viking-therapeutics-vktx-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PBE","LU1061106388.HKD","LU0122379950.USD","IE00BJJMRZ35.SGD","BIB","LU0320765992.SGD","LABU","LU2242646821.SGD","LU2242652126.USD","LU0868494617.USD","LU2468319806.SGD","XLV","AMGN","BBH","LU0109394709.USD","LU2089984988.USD","BK4137","LU0289739699.SGD","LU1057294990.SGD","BK4566","LU0128526141.USD","LU1571399168.USD","OZEM","IE00B4R5TH58.HKD","PJP","XBI","IE0009355771.USD","LU0029874061.USD","IE00BFTCPJ56.SGD","SG9999001440.SGD","IE00B2B36J28.USD","BK4585","LU1983299246.USD","BK4599","IBB","BK4533","IE0002141913.USD","BK4139","LU0889565916.HKD","TBXU","LU2112291526.USD","VKTX","BK4534","BK4588","LU0058720904.USD","HCSG","IE00BJT1NW94.SGD","IBBQ","ELDN","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669123184","title":"Amgen Inc Stock (AMGN) Moved Up by 3.90% on Sep 22: Facts Behind the Movement","url":"https://stock-news.laohu8.com/highlight/detail?id=2669123184","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669123184?lang=en_us&edition=fundamental","pubTime":"2026-09-22 23:15","pubTimestamp":1790090123,"startTime":"0","endTime":"0","summary":"• Amgen shares rose following positive Phase 3 OASIZ 301 trial results for dazodalibep.  \n• The company reported an annual revenue of $36.75B and a net profit of $7.71B.  \n• Analysts hold an average price target of $389.14 with a Hold rating.","market":"other","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262180812-market-movers-amgn-20260922","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","LU0889565916.HKD","IE00B4R5TH58.HKD","LU1023059063.AUD","BK4139","04332","LU0122379950.USD","IE0002141913.USD","PBE","LU2468319806.SGD","IE00BFTCPJ56.SGD","LU0289739699.SGD","BK4599","IE00BJJMRZ35.SGD","LU0868494617.USD","LU2112291526.USD","LU1061106388.HKD","IE00B2B36J28.USD","LU2242646821.SGD","LU0058720904.USD","LU1057294990.SGD","LU1571399168.USD","PJP","LU2242652126.USD","BK4588","IE0009355771.USD","LU1983299246.USD","LU0320765992.SGD","BK4533","SG9999001440.SGD","LU2089984988.USD","BBH","AMGN","IBBQ","BK4566","LU0109394709.USD","BK4581","IBB","BK4585","TBXU","IE00BJT1NW94.SGD","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669821123","title":"Competitive profile of Amgen’s dazodalibep still ‘open question,’ says Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2669821123","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669821123?lang=en_us&edition=fundamental","pubTime":"2026-09-22 22:55","pubTimestamp":1790088920,"startTime":"0","endTime":"0","summary":"Citi says Amgen’s (AMGN) dazodalibep delivered “positive” Phase 3 results in systemic Sjogren’s, which reduces clinical risk for “a potentially und...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/competitive-profile-of-amgens-dazodalibep-still-open-question-says-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/competitive-profile-of-amgens-dazodalibep-still-open-question-says-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1057294990.SGD","BK4534","IE00BJJMRZ35.SGD","BBH","PBE","LU0320765992.SGD","BK4599","LU0122379950.USD","LU0889565916.HKD","LU0868494617.USD","BK4585","BIB","LU1983299246.USD","BK4581","SG9999001440.SGD","IE0009355771.USD","IE0002141913.USD","LU0058720904.USD","IBB","AMGN","IE00B2B36J28.USD","IBBQ","LU2112291526.USD","LU1023059063.AUD","IE00B4R5TH58.HKD","BK4588","IE00BFTCPJ56.SGD","BK4566","LU0289739699.SGD","IE00BJT1NW94.SGD","PJP","LU2242646821.SGD","LU2242652126.USD","LU1061106388.HKD","LU2089984988.USD","LU2468319806.SGD","BK4533","TBXU","LU0109394709.USD","LU1571399168.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669128999","title":"Truist sees ‘significant positive readthrough’ for Maze from Vertex data","url":"https://stock-news.laohu8.com/highlight/detail?id=2669128999","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669128999?lang=en_us&edition=fundamental","pubTime":"2026-09-22 22:30","pubTimestamp":1790087413,"startTime":"0","endTime":"0","summary":"Truist analyst Danielle Brill views Vertex’s (VRTX) positive Phase 2 topline data as a meaningful validation of APOL1 inhibition in classic APOL1-m...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/truist-sees-significant-positive-readthrough-for-maze-from-vertex-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/truist-sees-significant-positive-readthrough-for-maze-from-vertex-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","IE00BZ9MQY76.HKD","IE0009355771.USD","LU0889565916.HKD","LU1674673428.USD","IE00B19Z9P08.USD","LU0757428866.USD","IE00B19Z3581.USD","BK4532","LU2089984988.USD","BBH","LU0256863811.USD","LU1559883803.SGD","BK4023","LU1778281490.HKD","TBXU","LU0061475181.USD","IE0002141913.USD","LU0823416689.USD","SGXZ57979304.SGD","SG9999013999.USD","LU1585245621.USD","IDNA","IE00BJJMRZ35.SGD","GNMX","IE00B19Z3B42.SGD","PBE","IE0002270589.USD","LU1069344957.HKD","LU1093756168.USD","LU1093756325.SGD","BK4533","LU2362540622.SGD","LU2462157665.USD","LU1035775433.USD","IE00B894F039.SGD","LU0058720904.USD","IBBQ","VRTX","IE00B19Z9Z06.USD","LU1674673691.USD","BIB","LU0079474960.USD","IE00B4R5TH58.HKD","LU0320765992.SGD","LU0289739699.SGD","LU2362541513.USD","VERX","LU2456880835.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669919128","title":"Maze jumps 25% to $27.99 after Vertex kidney disease data","url":"https://stock-news.laohu8.com/highlight/detail?id=2669919128","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669919128?lang=en_us&edition=fundamental","pubTime":"2026-09-22 22:25","pubTimestamp":1790087125,"startTime":"0","endTime":"0","summary":"10:23 EDT Maze jumps 25% to $27.99 after Vertex kidney disease data Published first on TheFly – the ultimate source for real-time, market-moving br...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/maze-jumps-25-to-27-99-after-vertex-kidney-disease-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/maze-jumps-25-to-27-99-after-vertex-kidney-disease-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VERX","IE00B19Z3581.USD","LU0432979614.USD","IE00BZ9MQY76.HKD","VRTX","LU0256863811.USD","LU1093756168.USD","LU0889565916.HKD","IE00B894F039.SGD","LU2362541273.HKD","BBH","BK4139","LU0320765992.SGD","LU1674673428.USD","PBE","LU1559883803.SGD","LU0058720904.USD","SG9999013999.USD","BK4567","LU0234570918.USD","IE0009355771.USD","IE00B19Z9P08.USD","LU2089984988.USD","BIB","IE00B19Z9Z06.USD","IE00BJT1NW94.SGD","SGXZ57979304.SGD","BK4023","IE0002141913.USD","LU0079474960.USD","BK4533","IBB","LU2362541513.USD","TBXU","IBBQ","IE0002270589.USD","LU1778281490.HKD","IDNA","LU2456880835.USD","GNMX","BK4585","LU2236285917.USD","LU0289739699.SGD","IE00BFTCPJ56.SGD","LU0109394709.USD","LU1585245621.USD","LU1815336091.USD","LU2417539215.USD","LU1093756325.SGD","LU2462157665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669470171","title":"Amgen Rises After Autoimmune Drug Meets Late-Stage Trial Goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2669470171","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669470171?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:48","pubTimestamp":1790084894,"startTime":"0","endTime":"0","summary":"BUZZ-Amgen rises after autoimmune drug meets late-stage trial goal** Shares of drugmaker AmgenAMGN.Orise 2.4% to $402.69** Co says its experimental drug, dazodalibep, for Sjogren's diseasemet the main goalof reducing disease activity in a late-stage trial** Sjogren's disease is an autoimmune disorder that causes dryness of the eyes, mouth and other parts of the body, along with fatigue and chronic pain** Drug showed a statistically significant and clinically meaningful improvement at week 48; most side effects were mild to moderate** Co plans to present detailed results at an upcoming medical meeting** Including session's move, AMGN up 23.1% YTD","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nL4N45E0WO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242646821.SGD","IE0009355771.USD","IE00B2B36J28.USD","LU0058720904.USD","IE00BFTCPJ56.SGD","BBH","LU0109394709.USD","LU0868494617.USD","BK4566","LU1057294990.SGD","LU0122379950.USD","LU0889565916.HKD","BK4599","BK4534","LU2112291526.USD","BK4588","IE0002141913.USD","IE00BJJMRZ35.SGD","PJP","PBE","IBB","SG9999001440.SGD","BK4585","LU1983299246.USD","BK4139","BK4533","TBXU","IBBQ","LU0289739699.SGD","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","AMGN","LU1571399168.USD","BK4581","LU2468319806.SGD","LU0320765992.SGD","LU1023059063.AUD","BIB","LU2089984988.USD","LU2242652126.USD","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669147050","title":"Amgen Says Dazodalibep Meets Primary Endpoint in Phase 3 Sjögren's Disease Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2669147050","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669147050?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:45","pubTimestamp":1790084715,"startTime":"0","endTime":"0","summary":"Sept 22 (Reuters) - Amgen Inc::*AMGEN: PHASE 3 OASIZ 303 STUDY OF DAZODALIBEP IN MODERATE-TO-SEVERE SYMPTOMATIC SJGREN’S DISEASE EXPECTED TO COMPLETE IN Q4 2026*AMGEN: DAZODALIBEP MEETS PRIMARY ENDPOI","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nRSDcc0x9T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","TBXU","SG9999001440.SGD","AMGN","IE00B4R5TH58.HKD","PJP","IE00BJJMRZ35.SGD","LU0320765992.SGD","IE0002141913.USD","IE00BFTCPJ56.SGD","IBBQ","LU1057294990.SGD","LU2112291526.USD","BK4533","PBE","BK4581","IE00B2B36J28.USD","LU2242646821.SGD","LU2242652126.USD","LU2468319806.SGD","LU1571399168.USD","BIB","LU0289739699.SGD","BBH","IE0009355771.USD","BK4585","LU1983299246.USD","IE00BJT1NW94.SGD","BK4588","LU0058720904.USD","BK4139","LU1023059063.AUD","LU0109394709.USD","BK4534","BK4599","IBB","LU0868494617.USD","LU2089984988.USD","LU1061106388.HKD","LU0122379950.USD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669147177","title":"Amgen Shares up 3% After Co's Autoimmune Disease Drug Succeeds in Late-Stage Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2669147177","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669147177?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:36","pubTimestamp":1790084178,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nL4N45E0VV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0320765992.SGD","BK4585","LU0289739699.SGD","BK4599","IE0002141913.USD","LU0109394709.USD","PJP","IE00B2B36J28.USD","LU0889565916.HKD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LU0122379950.USD","BK4534","LU1983299246.USD","IE00BJT1NW94.SGD","LU2468319806.SGD","BBH","BK4588","LU2112291526.USD","BK4566","LU1061106388.HKD","LU2242646821.SGD","BK4581","BIB","IE0009355771.USD","LU1057294990.SGD","LU0868494617.USD","PBE","TBXU","IBBQ","SG9999001440.SGD","LU0058720904.USD","LU1571399168.USD","IE00BFTCPJ56.SGD","BK4139","AMGN","BK4533","IBB","LU2089984988.USD","LU2242652126.USD","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669414223","title":"Amgen Says Phase 3 Trial Shows Dazodalibep Cuts Systemic Disease Activity in Sjögren’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2669414223","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669414223?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:04","pubTimestamp":1790082271,"startTime":"0","endTime":"0","summary":"Amgen says Phase 3 trial shows dazodalibep cuts systemic disease activity in Sjgren’s diseaseAmgen reported positive topline Phase 3 results for dazodalibep in adults with moderate-to-severe systemic ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL63L4Jz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0122379950.USD","LU0889565916.HKD","IE0009355771.USD","LU0109394709.USD","BK4581","TBXU","LU1983299246.USD","PJP","LU1023059063.AUD","LU2468319806.SGD","BK4534","LU2242652126.USD","LU0320765992.SGD","LU0868494617.USD","LU0058720904.USD","IBBQ","LU0289739699.SGD","IE00B2B36J28.USD","PBE","IE00BJJMRZ35.SGD","IE0002141913.USD","LU1057294990.SGD","BK4139","BK4566","LU2242646821.SGD","SG9999001440.SGD","LU1571399168.USD","BK4585","BIB","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","LU1061106388.HKD","IBB","LU2112291526.USD","BBH","IE00BJT1NW94.SGD","BK4599","BK4588","BK4533","LU2089984988.USD","AMGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669142464","title":"Vertex Pharmaceuticals Incorporated Says Inaxaplin Reduces UACR by -42.7% at Week 13 in AMKD with Modest Proteinuria","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142464","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669142464?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:02","pubTimestamp":1790082154,"startTime":"0","endTime":"0","summary":"Sept 22 (Reuters) - Vertex Pharmaceuticals Incorporated::*VERTEX ANNOUNCES POSITIVE RESULTS FROM PHASE 2B AMPLIFIED STUDY OF INAXAPLIN IN ADDITIONAL POPULATIONS OF PEOPLE WITH APOL1-MEDIATED KIDNEY DI","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nRSD66vtCD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0079474960.USD","LU2362540622.SGD","IBB","BK4533","PBE","LU1674673691.USD","IE00BFTCPJ56.SGD","LU0234570918.USD","LU0823416689.USD","LU0289739699.SGD","LU2237438978.USD","VRTX","LU2468319806.SGD","BK4532","BK4567","LU2362541513.USD","GNMX","LU1093756168.USD","LU2089984988.USD","LU0432979614.USD","LU1035775433.USD","IE00B2B36J28.USD","LU2236285917.USD","LU0256863811.USD","BK4585","IE0002141913.USD","BK4139","IE00B4R5TH58.HKD","IE0009355771.USD","LU0320765992.SGD","IDNA","IE00B894F039.SGD","LU0417517546.SGD","LU2362541273.HKD","LU0889565916.HKD","BIB","IE00BJT1NW94.SGD","BBH","BK4588","IE00B19Z3B42.SGD","IE00B19Z9P08.USD","SG9999001176.SGD","LU0061475181.USD","TBXU","SG9999013999.USD","LU1093756325.SGD","IBBQ","LU2417539215.USD","IE00B19Z9Z06.USD","IE00BZ9MQY76.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669142967","title":"Amgen Announces Positive Topline Phase 3 Results for Dazodalibep in Moderate-to-Severe Systemic SjÖGren's Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142967","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669142967?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:00","pubTimestamp":1790082029,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nFWN45E0FE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0889565916.HKD","PJP","BBH","BIB","BK4534","LU2468319806.SGD","BK4581","LU1571399168.USD","LU2089984988.USD","IE00BJJMRZ35.SGD","BK4599","BK4588","LU0320765992.SGD","BK4585","IE0002141913.USD","LU0109394709.USD","LU2242646821.SGD","LU0868494617.USD","IE0009355771.USD","LU1023059063.AUD","AMGN","IE00B4R5TH58.HKD","IE00B2B36J28.USD","LU1057294990.SGD","LU0058720904.USD","LU0122379950.USD","LU1061106388.HKD","LU1983299246.USD","BK4533","LU0289739699.SGD","IBBQ","PBE","BK4139","BK4566","LU2242652126.USD","LU2112291526.USD","SG9999001440.SGD","TBXU","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669142945","title":"Amgen: Dazodalibep Showed Statistically Significant & Clinically Meaningful Improvement in Systemic Disease Activity","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142945","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669142945?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:00","pubTimestamp":1790082000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nP8N3Z20GZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0889565916.HKD","PJP","BBH","BIB","BK4534","LU2468319806.SGD","BK4581","LU1571399168.USD","LU2089984988.USD","IE00BJJMRZ35.SGD","BK4599","BK4588","LU0320765992.SGD","BK4585","IE0002141913.USD","LU0109394709.USD","LU2242646821.SGD","LU0868494617.USD","IE0009355771.USD","LU1023059063.AUD","AMGN","IE00B4R5TH58.HKD","IE00B2B36J28.USD","LU1057294990.SGD","LU0058720904.USD","LU0122379950.USD","LU1061106388.HKD","LU1983299246.USD","BK4533","LU0289739699.SGD","IBBQ","PBE","BK4139","BK4566","LU2242652126.USD","LU2112291526.USD","SG9999001440.SGD","TBXU","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669142617","title":"Amgen: Phase 3 Oasiz 303 Study of Dazodalibep in Moderate-to-Severe Symptomatic SjÖGren’s Disease Expected to Complete in Q4 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142617","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669142617?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:00","pubTimestamp":1790082000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nP8N3Z20GZ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1057294990.SGD","BK4534","IE00BJJMRZ35.SGD","BBH","PBE","LU0320765992.SGD","BK4599","LU0122379950.USD","LU0889565916.HKD","LU0868494617.USD","BK4585","BIB","LU1983299246.USD","BK4581","SG9999001440.SGD","IE0009355771.USD","IE0002141913.USD","LU0058720904.USD","IBB","AMGN","IE00B2B36J28.USD","IBBQ","LU2112291526.USD","LU1023059063.AUD","IE00B4R5TH58.HKD","BK4588","IE00BFTCPJ56.SGD","BK4566","LU0289739699.SGD","IE00BJT1NW94.SGD","PJP","LU2242646821.SGD","LU2242652126.USD","LU1061106388.HKD","LU2089984988.USD","LU2468319806.SGD","BK4533","TBXU","LU0109394709.USD","LU1571399168.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}]}}